Vaxart Inc NB11-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 8:02 AM CEST
3.28quote price arrow down-0.04 (-1.09%)
52 week range
2.13 - 8.75
Loading...
  • Open3.28
  • Day High3.28
  • Day Low3.28
  • Prev Close3.28
  • 52 Week High8.75
  • 52 Week High Date08/10/21
  • 52 Week Low2.13
  • 52 Week Low Date05/10/22

Key Stats

  • Market Cap403.95M
  • Shares Out125.84M
  • 10 Day Average Volume1,589.18
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-41.3

KEY STATS

  • Open3.28
  • Day High3.28
  • Day Low3.28
  • Prev Close3.28
  • 52 Week High8.75
  • 52 Week High Date08/10/21
  • 52 Week Low2.13
  • 52 Week Low Date05/10/22
  • Market Cap403.95M
  • Shares Out125.84M
  • 10 Day Average Volume1,589.18
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-41.3

RATIOS/PROFITABILITY

  • EPS (TTM)-0.58
  • P/E (TTM)-5.65
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date11/09/2012
  • Div Amount6.648
  • Split Date-
  • Split Factor-

Latest On Vaxart Inc

There is no recent news for this security.

Profile

MORE
Vaxart, Inc. is a clinical-stage biotechnology company that is primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) oral vaccine platform. Its programs include tablet vaccines designed to protect against coronavirus, norovirus, seasonal influenza and respiratory syncytial virus (RSV), as well as a therapeutic vaccine for human papillomavirus (HPV). The Company’s product pipeline includes...
Todd Davis
Independent Chairman of the Board
Andrei Floroiu
President, Chief Executive Officer, Director
Fuad Ahmad
Interim Chief Financial Officer
Address
170 Harbor Way, Suite 300
South San Francisco, CA
94080
United States